AVDL — Avadel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.11bn
- $2.06bn
- $169.12m
Press Digest: Wall Street Journal - June 30
ASL Strategic Value Fund targets Avadel board over Lumryz drug mismanagement, WSJ reports
Brief: Avadel Shareholder Seeks Ousting Drugmaker's Entire Board- WSJ
Brief: Avadel Pharmaceuticals Says DC Court Of Appeals Upholds FDA Approval Of LUMRYZ - SEC Filing
Brief: Avadel announces grant of inducement awards under Nasdaq listing rule
Brief: Avadel Pharmaceuticals Receives Orphan Drug Designation From FDA For Lumryz
Brief: Avadel Pharmaceuticals Expands Leadership Team With Appointment Of Susan Rodriguez As Chief Operating Officer
Avadel Pharmaceuticals PLC reports results for the quarter ended March 31 - Earnings Summary
Brief: Avadel Pharmaceuticals Announces Favorable Ruling In Appeal Of Delaware Court Injunction
Avadel Pharmaceuticals PLC expected to post a loss of 7 cents a share - Earnings Preview
Brief: Avadel Pharmaceuticals To Provide A Corporate Update
Brief: Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-THOR Industries, TG Therapeutics, Target
U.S. STOCKS ON THE MOVE-Melco Resorts, Chipotle, Allegro
Avadel Pharmaceuticals PLC reports results for the quarter ended December 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Tesla, SolarEdge ,Protagonist
Avadel Pharmaceuticals rises on quarterly revenue beat
Brief: Avadel Pharmaceuticals Reiterates 2025 Guidance
Avadel Pharmaceuticals PLC expected to post a loss of 4 cents a share - Earnings Preview